Complete system activity log with compliance-grade audit trail.
Showing 32 of 32 events
| TIMESTAMP | ACTOR | ACTION | RESOURCE | DETAILS | SEVERITY |
|---|---|---|---|---|---|
| Apr 15, 1:07 AM | Dr. Sarah Chen(Prescriber) | Prescription Created | prescription:BPC-157 10mg | New prescription created for patient M.T. (42yo) -- Tissue Repair | INFO |
| Apr 15, 12:54 AM | Compliance Agent(Agent) | Compliance Check | prescription:BPC-157 10mg | California compliance check PASSED. 503A eligible. RAG verified (3 sources). | INFO |
| Apr 15, 12:41 AM | Pharmacy Admin(Ops) | Prescription Approved | prescription:BPC-157 10mg | Prescription approved for compounding. COA verified for Lot #PB-2026-0342. | INFO |
| Apr 15, 12:07 AM | Compliance Agent(Agent) | Compliance Check | compound:PT-141 | FLAGGED: PT-141 stability data expires in 14 days. COA renewal required. | WARNING |
| Apr 14, 11:49 PM | Shipping Agent(Agent) | Shipment Created | shipment:FedEx Priority Overnight | Shipping label generated for ORD-2026-0187. Tracking: 794644790132. Cold chain verified. | INFO |
| Apr 14, 11:13 PM | QC Agent(Agent) | Order Status Changed | order:BPC-157 10mg | QC passed. Potency: 99.2%. pH: 7.0. Visual inspection: clear solution, no particulates. | INFO |
| Apr 14, 10:19 PM | Dr. James Wright(Prescriber) | Login | session:Prescriber Portal | Login from San Diego, CA. MFA verified. | INFO |
| Apr 14, 9:49 PM | Formulary Intelligence Agent(Agent) | Evidence Updated | compound:BPC-157 | Evidence grade updated to B+ based on new systematic review (PubMed ID: 39284721). | INFO |
| Apr 14, 9:19 PM | Compliance Agent(Agent) | Compliance Check | prescription:Tirzepatide 5mg | BLOCKED: Prescriber license verification pending for Dr. Robert Kim. Manual review required. | CRITICAL |
| Apr 14, 8:19 PM | Pharmacy Admin(Ops) | Config Changed | agent:Shipping Agent | Updated shipping agent schedule from hourly to every 30 minutes. | INFO |
| Apr 14, 7:19 PM | Compounding Tech(Ops) | Order Status Changed | order:Semaglutide 2.5mg | Compounding started. Batch #SM-2026-0156. Estimated completion: 4 hours. | INFO |
| Apr 14, 5:19 PM | Formulary Intelligence Agent(Agent) | COA Uploaded | document:COA - TB-500 Lot #TB-2026-0218 | Auto-indexed COA document. Purity: 98.7%. Endotoxin: <0.25 EU/mg. PASS. | INFO |
| Apr 14, 3:19 PM | Dr. Sarah Chen(Prescriber) | Prescription Submitted | prescription:Thymosin Alpha 1 10mg | Prescription submitted for pharmacy review. Protocol: Thymosin Alpha-1 Immune Protocol. | INFO |
| Apr 14, 1:19 PM | Shipping Agent(Agent) | Shipment Status Changed | shipment:FedEx Priority Overnight | Delivery confirmed for ORD-2026-0181. Signed by: Front Desk at Chen Regenerative Medicine. | INFO |
| Apr 14, 11:19 AM | QC Agent(Agent) | Agent Action | batch:NAD+ 500mg Batch | WARNING: Minor sterility test delay for NAD+ batch. Extended incubation required. ETA: 24h. | WARNING |
| Apr 14, 7:19 AM | Pharmacy Admin(Ops) | Formulary Updated | compound:Tirzepatide | Stock status changed to LOW_STOCK. Current inventory: 8 vials. Reorder threshold: 10. | WARNING |
| Apr 14, 3:19 AM | Dr. Maria Santos(Prescriber) | Prescription Created | prescription:Testosterone Cypionate 200mg | New prescription for patient R.K. (55yo) -- Hormone Optimization. TRT protocol selected. | INFO |
| Apr 14, 1:19 AM | CDS Agent(Agent) | Agent Action | session:CDS Session - TRT | Generated testosterone replacement protocol. Evidence grade: A. Monitoring schedule included. | INFO |
| Apr 13, 11:19 PM | Dr. Lisa Park(Prescriber) | Login | session:Prescriber Portal | Login from Portland, OR. MFA verified. | INFO |
| Apr 13, 7:19 PM | Compliance Agent(Agent) | Compliance Check | compound:Semaglutide | Florida compliance check: RESTRICTED. Compounded Semaglutide limited under state law. Prescriber notified. | CRITICAL |
| Apr 13, 1:19 PM | Formulary Intelligence Agent(Agent) | Evidence Updated | compound:TB-500 | Research grade upgraded from B to B+ based on Phase II trial data (n=120, p<0.01). | INFO |
| Apr 13, 7:19 AM | Compounding Tech(Ops) | Order Status Changed | order:Selank + Semax Nasal | Compounding completed. Dual nasal spray preparation. Sent to QC review. | INFO |
| Apr 13, 1:19 AM | Shipping Agent(Agent) | Shipment Created | shipment:FedEx Priority Overnight | Label generated for ORD-2026-0180. Tracking: 794644790175. Standard packaging (room temp). | INFO |
| Apr 12, 9:19 PM | QC Agent(Agent) | Order Status Changed | order:Testosterone Cypionate 200mg | QC passed. Potency: 198mg/mL (within spec). Visual: clear, amber oil. | INFO |
| Apr 12, 1:19 PM | Pharmacy Admin(Ops) | Product Edited | compound:Glutathione Topical | Updated product description and storage requirements. | INFO |
| Apr 12, 1:19 AM | Compliance Agent(Agent) | Compliance Check | prescriber:Dr. Robert Kim | Prescriber verification PENDING. Florida medical license renewal in progress. Manual review required. | CRITICAL |
| Apr 11, 5:19 PM | CDS Agent(Agent) | Agent Action | protocol:GLP-1 RA Protocol | Updated Semaglutide titration schedule based on latest ADA guidelines. | INFO |
| Apr 11, 1:19 AM | Dr. Sarah Chen(Prescriber) | Login | session:Prescriber Portal | Login from Los Angeles, CA. MFA verified. | INFO |
| Apr 10, 1:19 AM | Formulary Intelligence Agent(Agent) | Formulary Updated | compound:NAD+ IV | Updated NAD+ protocols with new IV administration guidelines from longevity medicine literature. | INFO |
| Apr 9, 1:19 AM | Pharmacy Admin(Ops) | Config Changed | system:System Configuration | Enabled new QC checklist template for injectable compounds. | INFO |
| Apr 8, 7:19 PM | Shipping Agent(Agent) | Agent Action | carrier:DHL Express | Negotiated improved cold chain rates for international peptide shipments. Savings: 12%. | INFO |
| Apr 8, 9:19 AM | Compliance Agent(Agent) | Compliance Check | compound:Testosterone Cypionate | DEA Schedule III verification completed for all 50 states. All prescribers have valid DEA registrations. | INFO |